Background and objective: One of the chief causes of death in patients with β-thalassemia major (TM) remains heart failure due to iron overload. We investigated possible differences in myocardial function between a population of young asymptomatic patients with TM and healthy controls all of whom underwent an echocardiographic study, including tissue Doppler (TDI) and strain imaging (SI) analysis and cardiac magnetic resonance imaging (MRI). Methods: 30 young asymptomatic patients with TM (16 taking deferoxamine and 14 taking deferiprone) and 30 healthy subjects underwent a cardiac MRI with T2* technique and an echocardiographic evaluation including systolic myocardial velocities (Sm), early (Em) and late (Am) diastolic velocities and systolic strain (S) at the level of basal segments of the lateral left ventricle (LV), interventricular septum (Septal) and lateral right ventricle (RV) wall. The differences in T2* values and echocardiographic parameters were also compared in patients with TM subgrouped according to iron chelation therapy. Results: The following TDI and SI measures were lower in patients than in controls: LV-Sm (P < 0.05), S-LV (P < 0.001), Septal-Sm (P < 0.05), Septal-Em (P < 0.001), S-Septal (P < 0.001), RV-Sm (P < 0.001), RV-Em (P < 0.001), RV-Em/Am (P < 0.05) and S-RV (P < 0.05). Myocardial function was better in the patients receiving deferiprone than those receiving deferoxamine. T2* values were higher in controls than in patients with TM and in those treated with deferiprone than those treated with deferoxamine. MRI data well correlated with SI parameters. Conclusions: Study underlines that, even in a population of young, asymptomatic and well-chelated patients with TM, there is an impairment of myocardial function and that this condition could be easily detected by more advanced ultrasound techniques such as TDI and SI. The better indices of myocardial function in patients treated with deferiprone clearly needs confirmation from larger prospective studies

Magrì, D., Sciomer, S., Fedele, F., Gualdi, G., Casciani, E., Pugliese, P., et al. (2008). Early impairment of myocardial function in young patients with beta-thalassemia major. EUROPEAN JOURNAL OF HAEMATOLOGY, 80(6), 515-522 [10.1111/j.1600-0609.2008.01054.x].

Early impairment of myocardial function in young patients with beta-thalassemia major

Casciani E;
2008-01-01

Abstract

Background and objective: One of the chief causes of death in patients with β-thalassemia major (TM) remains heart failure due to iron overload. We investigated possible differences in myocardial function between a population of young asymptomatic patients with TM and healthy controls all of whom underwent an echocardiographic study, including tissue Doppler (TDI) and strain imaging (SI) analysis and cardiac magnetic resonance imaging (MRI). Methods: 30 young asymptomatic patients with TM (16 taking deferoxamine and 14 taking deferiprone) and 30 healthy subjects underwent a cardiac MRI with T2* technique and an echocardiographic evaluation including systolic myocardial velocities (Sm), early (Em) and late (Am) diastolic velocities and systolic strain (S) at the level of basal segments of the lateral left ventricle (LV), interventricular septum (Septal) and lateral right ventricle (RV) wall. The differences in T2* values and echocardiographic parameters were also compared in patients with TM subgrouped according to iron chelation therapy. Results: The following TDI and SI measures were lower in patients than in controls: LV-Sm (P < 0.05), S-LV (P < 0.001), Septal-Sm (P < 0.05), Septal-Em (P < 0.001), S-Septal (P < 0.001), RV-Sm (P < 0.001), RV-Em (P < 0.001), RV-Em/Am (P < 0.05) and S-RV (P < 0.05). Myocardial function was better in the patients receiving deferiprone than those receiving deferoxamine. T2* values were higher in controls than in patients with TM and in those treated with deferiprone than those treated with deferoxamine. MRI data well correlated with SI parameters. Conclusions: Study underlines that, even in a population of young, asymptomatic and well-chelated patients with TM, there is an impairment of myocardial function and that this condition could be easily detected by more advanced ultrasound techniques such as TDI and SI. The better indices of myocardial function in patients treated with deferiprone clearly needs confirmation from larger prospective studies
2008
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/23
Settore MEDS-22/A - Diagnostica per immagini e radioterapia
English
Con Impact Factor ISI
Echocardiography
Magnetic resonance imaging
Strain imaging
Tissue Doppler imaging
β-thalassemia major
Magrì, D., Sciomer, S., Fedele, F., Gualdi, G., Casciani, E., Pugliese, P., et al. (2008). Early impairment of myocardial function in young patients with beta-thalassemia major. EUROPEAN JOURNAL OF HAEMATOLOGY, 80(6), 515-522 [10.1111/j.1600-0609.2008.01054.x].
Magrì, D; Sciomer, S; Fedele, F; Gualdi, G; Casciani, E; Pugliese, P; Losardo, A; Ferrazza, G; Pasquazzi, E; Schifano, E; Mussino, E; Quaglione, R; P...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
43) Early impairment of myocardial function in - Eur J Haematol 2008.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright degli autori
Dimensione 291.97 kB
Formato Adobe PDF
291.97 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/400393
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 41
social impact